IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	15.5	23.39	50.93	27.94	19.54	0
Revenue Growth (YoY)	-67.33%	-54.08%	82.28%	43.01%	-	-
Gross Profit	15.5	23.39	50.93	27.94	19.54	0
Selling, General & Admin	30.22	28.31	23.9	20.05	15.18	9.95
Research & Development	144.45	129.51	89.54	58.16	39.7	34.32
Operating Expenses	174.67	157.81	113.43	78.21	54.88	44.27
Operating Income	-159.17	-134.43	-62.5	-50.27	-35.34	-44.27
Other Expense / Income	-30.28	-21.47	-3.85	-0.51	-0.85	-2.3
Pretax Income	-128.89	-112.96	-58.66	-49.76	-34.5	-41.98
Net Income	-128.89	-112.96	-58.66	-49.76	-34.5	-41.98
Shares Outstanding (Basic)	75	58	41	35	25	12
Shares Outstanding (Diluted)	75	58	41	35	25	12
Shares Change	55.28%	38.79%	17.57%	42.60%	97.82%	1206.87%
EPS (Basic)	-2.01	-1.96	-1.42	-1.41	-1.40	-3.36
EPS (Diluted)	-2.01	-1.96	-1.42	-1.41	-1.40	-3.36
Free Cash Flow	-134.85	-117.59	-90.62	-58.42	54.97	-40.67
Free Cash Flow Per Share	-1.79	-2.04	-2.19	-1.66	2.22	-3.25
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-1026.63%	-574.85%	-122.72%	-179.91%	-180.90%	-
Profit Margin	-831.35%	-483.05%	-115.17%	-178.10%	-176.55%	-
Free Cash Flow Margin	-869.74%	-502.85%	-177.92%	-209.09%	281.35%	-
EBITDA	-124.76	-108.95	-55.14	-46.73	-33.11	-40.73
EBITDA Margin	-804.71%	-465.91%	-108.26%	-167.25%	-169.49%	-
Depreciation & Amortization	4.13	4.01	3.52	3.03	1.38	1.25
EBIT	-128.89	-112.96	-58.66	-49.76	-34.5	-41.98
EBIT Margin	-831.35%	-483.05%	-115.17%	-178.10%	-176.55%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).